Ocular Drug Delivery
preclinical ocular drug development
Therapeutics Ocular drug development
terms of drug targets
new drug candidates
innovative drug delivery technologies
local drug administration routes
drug treatment of retinal diseases
unique field
major field
development of drugs
proposal
experts of preclinical ocular R
experts of ophthalmology
field of expanding importance
success of European pharmaceutical industry
industrial researchers
future competitiveness of European science
companies
European big pharma
thesis projects
inter-sectoral education
local toxicity issues
pharmaceutical scientists
materials science
major challenge
Educational Network
main objective
industrial partner laboratories
unique combination of innovation
Early Stage Researchers
pharmacokinetics
tissue barriers
activity
formulation challenges
course programme
end-points
secondments
relevant fields
niche area
nanomedicine
research community
silico
forces
unmet needs
obvious need
methods
various partners
systems pharmacology
ESRs
outcomes